Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid

British Journal of Pharmacology
C A HarrisK H Jhamandas

Abstract

1. Nicotinylalanine, an inhibitor of kynurenine metabolism, has been shown to elevate brain levels of endogenous kynurenic acid, an excitatory amino acid receptor antagonist. This study examined the potential of nicotinylalanine to influence excitotoxic damage to striatal NADPH diaphorase (NADPH-d) and gamma-aminobutyric acid (GABA)ergic neurones that are selectively lost in Huntington's disease. 2. A unilateral injection of the N-methyl-D-aspartate (NMDA) receptor agonist, quinolinic acid, into the rat striatum produced an 88% depletion of NADPH-d neurones. Intrastriatal infusion of quinolinic acid also produced a dose-dependent reduction in striatal GABA content. 3. Nicotinylalanine (2.3, 3.2, 4.6, 6.4 nmol 5 microl(-1), i.c.v.) administered with L-kynurenine (450 mg kg(-1)), a precursor of kynurenic acid, and probenecid (200 mg kg(-1)), an inhibitor of organic acid transport, 3 h before the injection of quinolinic acid (15 nmol) produced a dose-related attenuation of the quinolinic acid-induced loss of NADPH-d neurones. Nicotinylalanine (5.6 nmol 5 microl(-1)) in combination with L-kynurenine and probenecid also attenuated quinolinic acid-induced reductions in striatal GABA content. 4. Nicotinylalanine (4.6 nmol, i.c.v.), L-...Continue Reading

References

Mar 1, 1992·Journal of the Neurological Sciences·M F BealE D Bird
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·J W Olney
Feb 1, 1986·Annals of Neurology·S M Rothman, J W Olney
Jan 1, 1985·Neurobiology of Aging·R J BoegmanS K Ludwin
Jan 1, 1974·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·K L SimsV M Pickel
Jul 2, 1984·Life Sciences·R SchwarczC Köhler
Jul 10, 1981·European Journal of Pharmacology·T W Stone, M N Perkins
Jan 1, 1993·Journal of Neurochemistry·C Speciale, R Schwarcz
Feb 1, 1993·Biochemical Society Transactions·R Schwarcz
Feb 1, 1993·Biochemical Society Transactions·M P Heyes
Jan 1, 1996·Advances in Experimental Medicine and Biology·J LuthmanB Fornstedt-Wallin
Jan 1, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·J UrenjakE Zilkha

❮ Previous
Next ❯

Citations

Jun 22, 2006·Neurotoxicity Research·M F BealT Archer
Jun 22, 2006·Neurotoxicity Research·K H JhamandasK A Lipic
Jul 21, 2009·Journal of Neural Transmission·D ZádoriL Vécsei
Jan 5, 2011·Journal of Neural Transmission·Dénes ZádoriPéter Klivényi
Jun 23, 2011·Journal of Neural Transmission·Trevor W StoneL Gail Darlington
Dec 1, 2012·Journal of Neural Transmission·Dénes ZádoriLászló Vécsei
Aug 2, 2002·European Journal of Pharmacology·Trevor W Stone, Jonas I Addae
Apr 12, 2000·European Journal of Medicinal Chemistry·T W Stone
May 24, 2000·Brain Research Bulletin·D PawlakA Takada
Dec 15, 2012·Nature Reviews. Drug Discovery·László VécseiJózsef Toldi
Jul 30, 2004·Molecular and Cellular Biology·Ping YuDanilo A Tagle
Sep 5, 2012·Expert Review of Clinical Pharmacology·Laszlo VecseiLevente Szalardy
Apr 3, 2001·Expert Opinion on Investigational Drugs·T W Stone
Feb 3, 2015·Journal of Cellular Biochemistry·Diba SheipouriNady Braidy
Apr 28, 2009·Progress in Neurobiology·Robert SchwarczPaul J Muchowski
Sep 26, 2007·The European Journal of Neuroscience·L G DarlingtonT W Stone
Jul 16, 2010·Journal of Cellular and Molecular Medicine·Zsigmond Tamas KincsesLászló Vécsei
Dec 16, 2010·Journal of Cellular and Molecular Medicine·Dénes ZádoriLászló Vécsei
Jan 4, 2006·Brain Research·Ferenc BariFerenc Domoki
Nov 23, 2005·Experimental Neurology·Joseph T Coyle
May 14, 2016·Expert Opinion on Therapeutic Patents·Dénes ZádoriLászló Vécsei
Nov 15, 2013·Therapeutic Advances in Neurological Disorders·Zsófia MajláthLászló Vécsei
Oct 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Arash RassoulpourRobert Schwarcz
Nov 20, 2018·Expert Opinion on Therapeutic Targets·Fanni A BorosLászló Vécsei
Aug 26, 2006·Journal of Neural Transmission·H-Q WuR Schwarcz
Jul 20, 2005·Epilepsia·Hui-Qiu WuRobert Schwarcz
Oct 31, 2002·Nature Reviews. Drug Discovery·Trevor W Stone, L Gail Darlington
Feb 15, 2019·Experimental & Molecular Medicine·Xiaozhong ZhengDamian J Mole
Jul 31, 2001·Pediatric Research·G Ceresoli-Borroni, R Schwarcz
Nov 7, 2019·Journal of Neurochemistry·Trevor W Stone
Jan 1, 2009·International Journal of Tryptophan Research : IJTR·Yiquan Chen, Gilles J Guillemin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.